Consumer Health

Dermatologicals is seeing steady single-digit growth in current value terms in 2023. Two of the most important product areas, topical antifungals and vaginal antifungals, are both seeing moderate growth in 2023, although this is largely due to…

Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…

Over 2023, dermatologicals is expected to see fast retail current value growth across categories, supported by rising prices amid a highly inflationary climate. In retail volume terms, growth is set to be positive, if more moderate than in current…

While overall consumer awareness of skin diseases and infections is increasing in Kenya, there remain areas where stigma persists, creating a reluctance among consumers to seek help. For instance, vaginal antifungals are linked to the stigma of…

Although dermatologicals continues to enjoy steady growth in 2023, current value sales have slowed down compared to the double-digit rates seen at the height of the COVID-19 pandemic. Whilst spending more time at home, Latvian consumers became…

The dermatologicals landscape is experiencing a downward momentum in some categories, which have found themselves losing share and importance following the outbreak of COVID-19. Topical Germicidals/Antiseptics is one of the categories which is set to…

Dermatologicals saw an overall increase in demand in 2023, although performance varied somewhat by subcategory Nappy (diaper) rash treatments, for example, benefited from the return of consumers to more active lifestyles outside the home, which meant…

While sales of dermatologicals continue to grow in 2023, reflecting a recovery from pandemic-related disruptions. demand is stabilising. Mexicans are no longer facing increased risks to their skin compared to the previous year, and some…

Dermatologicals has performed impressively in 2023, with all categories set to record stronger volume growth rates than in 2022. Demand for some product types has picked up as the increased levels of social contact brought about by the easing of the…

Topical antifungals was one of the most dynamic subcategories within dermatologicals in current value terms in 2023, continuing the trend of the previous year. Following a sluggish performance during the first three years of the review period, such…

Climatic and social conditions drive the sale of paediatric dermatologicals products in Nigeria. As well as being more sensitive to environmental factors than adults, children’s lifestyles expose them to conditions that lead to skin problems,…

In line with the overall performance of skin care products in beauty and personal care in North Macedonia, dermatologicals is one of the fastest growing consumer health category thanks to strong and continued consumer demand. The product and brand…

Dermatologicals continued to record positive value growth in current price terms over the course of 2023 as the essential nature of many of these products for those experiencing moderate skin health issues ensured that demand remained relatively…

Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…

Dermatologicals, in some regards, are driven by environmental factors. As such, the emergence of the El Niño Costero climatological event, which increased temperatures in Peru, especially along the coast, ultimately resulted in a higher number of…

Most types of dermatologicals saw an upward sales trend in retail volume terms in 2023, although the rate of expansion was lower than that seen in many other consumer health categories. Despite the increasing incidence of diagnosed skin diseases…

Dermatologicals is set to register positive growth in current value and retail volume terms in 2023. With the WHO declaring the pandemic to be over in May 2023, there has been an increase in socialisation and physical contact between people which has…

International players with broad portfolios continue to lead the way in dermatologicals, with Bayer Romania the top-ranked company. Bayer Romania’s Canesten, the best-selling product in both topical and vaginal antifungals, is expected to maintain…

In 2023, dermatologicals is set to return to solid current value growth, although performances are expected to vary widely across categories. For instance, hair loss treatments is expected to continue to benefit from consumers’ perception of their…

The decline in consumers’ disposable income due to rising prices is dampening demand for consumer health products that are not seen as essential, such as many dermatologicals products. In the current economic climate in particular, Serbian consumers…